Radiotherapy and Radiosurgery for Metastatic Spine Disease What Are the Options, Indications, and Outcomes?

被引:243
作者
Gerszten, Peter C. [1 ,2 ]
Mendel, Ehud [3 ]
Yamada, Yoshiya [4 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
[3] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
关键词
outcomes; radiotherapy; radiosurgery; metastatic spine disease; FRACTIONATED STEREOTACTIC RADIOSURGERY; INTENSITY-MODULATED RADIOTHERAPY; RADIATION-INDUCED MYELOPATHY; CORD COMPRESSION SECONDARY; GUIDED HELICAL TOMOTHERAPY; LONG-COURSE RADIOTHERAPY; BREAST-CANCER; CLINICAL-EXPERIENCE; PROGNOSTIC-FACTORS; PARASPINAL TUMORS;
D O I
10.1097/BRS.0b013e3181b8b6f5
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Study Design. Systematic literature review. Objective. To determine the options, indications, and outcomes for conventional radiotherapy and radiosurgery for metastatic spine disease. Methods. Three research questions were determined through a consensus among a multidisciplinary panel of spine oncology experts. A systematic review of the literature was conducted regarding radiotherapy and radiosurgery for metastatic spine disease using PubMed, Embase, the Cochrane Evidence Based Medicine Database, and a review of bibliographies of reviewed articles. Research questions: 1. What are the clinical outcomes of the current indications for conventional radiotherapy alone and stereotactic radiosurgery for metastatic spine disease? 2. What are the current dose recommendations and fractionation schedules for conventional spine radiotherapy and stereotactic radiosurgery for metastatic spine disease? 3. What are the current known patterns of failure and complications after conventional spine radiation and stereotactic radiosurgery for metastatic spine disease? Results. For conventional radiotherapy, the initial literature search yielded a total of 531 potentially relevant abstracts. Each of these abstracts was reviewed for relevance, and 62 were selected for in-depth review. Fortynine studies met all the inclusion criteria. References from the articles included in the analysis and review articles were also examined for potential inclusion in the study. For conventional radiotherapy, 3 randomized trials (high-quality evidence), 4 prospective studies (moderate-quality evidence), and over 40 nonprospective data sets (low- or very-low-quality evidence) that included over 5000 patients in the literature were included in this review. Drawing from the same databases, a systematic search for radiosurgery yielded 195 abstracts, of which 29 met all inclusion criteria. They all represented single-institution reports (low-or very-low-quality data). No randomized data are available for spine radiosurgery. Conclusion. A systematic review of the available evidence suggests that conventional radiotherapy is safe and effective with good symptomatic response and local control, particularly for radiosensitive histologies. A strong recommendation can be made with moderate quality evidence that conventional fractionated radiotherapy is an appropriate initial therapy option for patients with spine metastases in cases in which no relative contraindication exists. A systematic review of the available evidence suggests that radiosurgery is safe and provides an incremental benefit over conventional radiotherapy with more durable symptomatic response and local control independent of histology, even in the setting of prior fractionated radiotherapy. A strong recommendation can be made with low-quality evidence that radiosurgery should be considered over conventional fractionated radiotherapy for the treatment of solid tumor spine metastases in the setting of oligometastatic disease and/or radioresistant histology.
引用
收藏
页码:S78 / S92
页数:15
相关论文
共 113 条
[1]
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression [J].
Aass, N ;
Fosså, SD .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :259-265
[2]
Amendola BE, 2000, CANCER J, V6, P88
[3]
A retrospective study of metastatic lung cancer compression of the cauda equina [J].
Ampil, FL ;
Mills, GM ;
Burton, GV .
CHEST, 2001, 120 (05) :1754-1755
[4]
METASTATIC SPINAL-CORD COMPRESSION SECONDARY TO LUNG-CANCER [J].
BACH, F ;
AGERLIN, N ;
SORENSEN, JB ;
RASMUSSEN, TB ;
DOMBERNOWSKY, P ;
SORENSEN, PS ;
HANSEN, HH .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1781-1787
[5]
Safety and efficacy of stereotactic radiosurgery for tumors of the spine [J].
Benzil, DL ;
Saboori, M ;
Mogilner, AY ;
Rocchio, R ;
Moorthy, CR .
JOURNAL OF NEUROSURGERY, 2004, 101 (03) :413-418
[6]
Operative management of metastatic and malignant primary subaxial cervical tumors [J].
Bilsky, MH ;
Boakye, M ;
Collignon, F ;
Kraus, D ;
Boland, P .
JOURNAL OF NEUROSURGERY-SPINE, 2005, 2 (03) :256-264
[7]
Intensity-modulated stereotactic radiotherapy of paraspinal tumors: A preliminary report [J].
Bilsky, MH ;
Yamada, Y ;
Yenice, KM ;
Lovelock, M ;
Hunt, M ;
Gutin, PH ;
Leibel, SA .
NEUROSURGERY, 2004, 54 (04) :823-830
[8]
Metastatic spinal cord compression in patients with colorectal cancer [J].
Brown P.D. ;
Stafford S.L. ;
Schild S.E. ;
Martenson J.A. ;
Schiff D. .
Journal of Neuro-Oncology, 1999, 44 (2) :175-180
[9]
Prospective health-related quality of life valuations (utilities) of 8 Gy in 1 fraction vs 30 Gy in 10 fractions for palliation of painful bone metastases: Preliminary results of RTOG 97-14 [J].
Bruner, DW ;
Winter, K ;
Hartsell, W ;
Konski, A ;
Curran, W ;
Roach, M ;
Doncals, D ;
Movsas, B ;
Lee, D ;
Scarantino, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01) :S142-S142
[10]
Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases [J].
Chang, EL ;
Shiu, AS ;
Lii, MF ;
Rhines, LD ;
Mendel, E ;
Mahajan, A ;
Weinberg, JS ;
Mathews, LA ;
Brown, BW ;
Maor, MH ;
Cox, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05) :1288-1294